The latest news on MS treatments, research and specialist services.
MS Trust news
News from the MS Trust
Views and comment
MS Trust staff, MS health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
Melissa tells us why she and her husband travelled 118 miles around Kent in a Nissan Cube, dressed in Halloween costumes.
- SNP backs decriminalising cannabis for medical use
- More MS nurses needed in West Yorkshire
- Tysabri (natalizumab) reduces depression in MS
- MS Society survey finds "disturbing levels" of workplace bullying
- Importance of family
Artist Becca Thomas, whose mother Rosemary recently passed away, is selling artworks in memory of her mum to help people with MS.
Bella and Charlie will be dressing as reindeer and taking part in a sponsored walk in honour of their dad Mike who has MS.
Further analysis of data from a clinical trial has shown that people taking Lemtrada were more likely to have an improvement in disability over the two years of the study, compared to people taking Rebif.
- How people with MS feel about risk
- Stress and onset of symptoms
- Lemtrada (alemtuzumab) and disability improvement
- Stress incontinence in women with MS
- Factors indicating how MS may develop
- Low dose naltrexone safety study
- Intimate relations
The MS Trust has created two relapse resources, one to support people living with MS and one for MS health professionals running relapse services.
Have you used the MS Trust information service since 1 September 2016? If you're living with MS or are the relative or close friend of someone who is, you could help us improve our information service for people with MS by taking part in a research study being conducted by an independent research agency.
What do early October, a church in London and Christmas cards have in common? They mark a very important event, as Claire from our fundraising team explains.
- ESA re-assessments
- NICE turns down daclizumab
- Mindfulness helps with coping
- Tysabri vs Gilenya comparison
The government are to scrap repeat assessments of people claiming ESA (Employment Support Allowance) if they have a condition that is unlikely to have improved.
Sleepless nights and jars of chutney from a neighbour inspired Marie to create her own cook book, which she is now using to raise funds to help others with MS.
Reports of studies presented at the ECTRIMS meeting that took place from 14-17 September 2016. Reports include research into disease modifying drugs for relapsing and progressive MS, stem cells and lifestyle factors in MS.
- MS at the Paralympics
- Gene research for progressive MS questioned
- Natural history of people on disease modifying drugs
- MPs support call for medical cannabis
- Film about footballer with MS released on DVD
- Older people with MS
- Ageing with MS
- Progressive MS research funding
- Guidelines on more than one long-term condition
- ECTRIMS round up
Siponimod reduced the risk of progression in secondary progressive MS (SPMS) according to results presented at the ECTRIMS meeting in London on 17 September.
- How heat affects people with MS
- Paralympians with MS
- Negative attitudes to people with MS
- Tamoxifen may help myelin repair
- Genes don't suggest course of MS
A new report from the MS Trust shows that two in three people with MS in the UK live in areas where there aren’t enough MS nurses to provide vital care and support.
- The effect of childhood MS on parents
- Review of the medical understanding of childhood MS
- Explaining MS
- Please offer me a seat
- How lifestyle factors affect MS
- Photography project focuses on MS
- Low white blood cell count and MS